PASADENA – The World Stem Cell Summit, now in its seventh year, will kick off three days of networking and seminars on Monday at the Pasadena Convention Center in hopes of spurring progress and investment in the emerging industry. The event promises more than 150 top international speakers and 50 hours of programming with industry leaders from science, pharmaceuticals, business, policy, ethics, law and more. Bernie Siegel, founder and co-chair of the Summit and executive director the Genetic Policy Institute (GPI), which produces the event, said this year’s focus on translational regenerative medicine is about asking “how do you take the phenomenal scientific research going on in labs and translate it into medical treatments? It’s a big job to do this, and more than just the science.”
Recent Posts
- Cracking a ‘holy grail’ challenge in cancer cell therapy
- New Bio-Implant for Spinal Cord Repair
- Seattle jury awards $24M in lawsuit against stem cell center
- Phase I/II study finds intravitreal CD34+ stem cells safe and feasible in CRVO
- After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate
- More Sensitive Cell Therapy May Be a HIT Against Solid Cancers

